La tunisie Medicale - 2022 ; Vol 100 ( n°08 ) : 592-602
[ 455 times seen ]

Objective: To measure the prevalence of metabolic syndrome and its components in the HSHS cohort (Hammam Sousse, Tunisia), in 2009, and to identify its determining factors.
Methods: This was a descriptive epidemiological study of the “community based” type having focused on a random sample of people aged 20 and over. The metabolic syndrome was defined according to the criteria of the “International Diabetes Federation” (IDF 2005) and those of the “National Cholesterol Education Program-Adult Treatment Panel III” (NCEP-ATP III, 2001).
Results: The study involved 1441 people including 960 women (66.6%). The age- and sex-adjusted prevalences of increased waist circumference, blood pressure, blood sugar and triglycerides, and decreased HDL-cholesterol were respectively 63.2%, 95%CI[62.5-63.8]; 47.7%, 95%CI[47.4-48.6]; 25.7%, 95%CI[25.1-26.2]; 11.9%, 95%CI[11.4-12.3] and 65,6%, 95%CI[65.0-66.2], according to IDF thresholds and 37.4%, 95%CI[36.3-37.6]; 45.7%, 95%CI[45.4-46.6]; 13.8%, 95%CI[13.4-14.2]; 8.4%, 95%CI[8.0-8.7] and 61.9%, 95%CI[61.2-62.5], according to those of the NCEP-ATP III. The prevalence of metabolic syndrome adjusted for age and sex was 36.5% 95%CI[33.0%-38.9%] according to the IDF definition and 23.0% 95%CI[20.4%-25.6%] according to that of NCEP-ATP III. The multivariate study by logistic regression made it possible to retain three significant independent determining factors of the metabolic syndrome: age ≥40 years, low level of physical activity and family history of diabetes mellitus with respectively adjusted ORs of 3.77 95%CI[2.70-5.27], 1.39 95%CI[1.01-1.89], 1.62 95%CI[1.21-2.15], according to IDF and 5.87 95%CI[3.88 -8.88], 1.47 95%CI[1.07-2.01] and 1.45 95%CI[1.07-1.96], according to NCEP-ATP III .
Conclusion: With this high prevalence rate of the metabolic syndrome, the establishment of an action plan would be essential. This plan should be based on the combination of the promotion of physical activity and screening for the components of the metabolic syndrome, particularly in subjects aged 40 or over, with a family history of diabetes mellitus.

Key - Words
  1. Babagoli M, Soleimani M, Baghdadi S, Vatan MS, Shafiei SH. Does metabolic syndrome increase the risk of fracture? A systematic review and meta-analysis. Arch Osteoporos. 31 août 2022;17(1):118.
  2. Delarue J, Allain G, Guillerm S. Le syndrome métabolique. Nutr Clin Métabolisme. 1 juin 2006;20(2):114-7.
  3. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 4 déc 2002;288(21):2709-16.
  4. Shin S, Jee H. Prevalence of metabolic syndrome in the Gulf Cooperation Council countries: meta-analysis of cross-sectional studies. J Exerc Rehabil. févr 2020;16(1):27-35.
  5. Pietropaoli D, Monaco A, Del Pinto R, Cifone MG, Marzo G, Giannoni M. Advanced glycation end products: possible link between metabolic syndrome and periodontal diseases. Int J Immunopathol Pharmacol. mars 2012;25(1):9-17.
  6. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12(6):295-300.
  7. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation. 30 sept 2003;108(13):1552-3.
  8. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 3 juin 2004;350(23):2362-74.
  9. Serrano Ríos M. [Metabolic syndrome: a modern variant of stress-related disease?]. Rev Esp Cardiol. juill 2005;58(7):768-71.
  10. Ghannem H, Hadj Fredj A. Prevalence of cardiovascular risk factors in the urban population of Soussa in Tunisia. J Public Health Med. déc 1997;19(4):392-6.
  11. Allal-Elasmi M, Haj Taieb S, Hsairi M, Zayani Y, Omar S, Sanhaji H, et al. The metabolic syndrome: prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis. Diabetes Metab. juin 2010;36(3):204-8.
  12. Mnif Feki M, Chakroun E, Sessi S, Charfi N, Dammak M, Kaffel N, et al. P199 Syndrome Métabolique dans la région de Sfax (Tunisie). Diabetes Metab. 1 mars 2008;34:H95.
  13. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med J Br Diabet Assoc. avr 2006;23(4):441-4.
  14. Khelil M. Prévalence et facteurs de risque de l’obésité dans la commune de Hammam Sousse (Tunisie). [Sousse]: Faculté de Médecine « Ibn El Jazzar »; 2011.
  15. Mbarki S, Ben Abdelaziz A, Ben Hassine D, Melki S, Ben Rejeb N, Omezzine A, et al. Epidemiology of diabetes mellitus in Tunisia. HSHS 2 study (Hammam Sousse Sahloul Heart Study). Tunis Med. mars 2022;100(3):229-40.
  16. Hamoudi A, Ben Abdelaziz A, Melki S, Ben Hassine D,Ben Rejeb N, Omezzine A, et al. Epidemiology of arterial hypertension in Tunisia: Hammam Sousse Sahloul Heart Study (HSHS). Tunis Med. fevrier 2022;100(2):167-79.
  17. Ben Hdia Z, Ben Abdelaziz A, Melki S, Ben Hassine D, Ben Rejeb B, Omezzine A. Épidemiologie de la dyslipidemie en Tunisie, Etude Hammam Sousse Sahloul Heart Study (HSHS 3*) Epidemiology of dyslipidemia in Tunisia, HSHS 3 study (Hammam Sousse Sahloul Heart Study). Tunis Med. 2022;100(4):323-34.
  18. Khalil S. Prévalence et facteurs determinants du tabagisme dans la commune de Hammam Sousse (Tunisie). [Sousse]: Faculté de Médecine « Ibn El Jazzar »; 2012.
  19. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med J Br Diabet Assoc. mai 2006;23(5):469-80.
  20. Organisation mondiale de la santé. STEPS : l’approche STEPwise de l’OMS pour la surveillance des facteurs de risque des maladies chroniques : manuel de surveillance STEPS de l’OMS [Internet]. 2006 [cité 25 sept 2022]. Disponible sur:
  21. Mehdioui F, Hellara I, Neffati F, Mezzour H, Fadhel Najjar M. Évaluation d’une technique enzymatique colorimétrique pour le dosage du cholestérol libre. Rev Francoph Lab. 1 mai 2009;2009(412):63-6.
  22. Cleeman J, National Heart, Lung, and Blood Institute. ATP III Guidelines At-A-Glance Quick Desk Reference [Internet]. 2001 [cité 27 août 2022]. Disponible sur: https://www.nhlbi.
  23. Organisation mondiale de la santé. Obésité : prévention et prise en charge de l’épidémie mondiale : rapport d’une consultation de l’OMS [Internet]. Genève: Organisation mondiale de la Santé; 2003 [cité 24 août 2022] p. 284. Disponible sur:
  24. Verma VK, Taneja V, Jaiswal A, Sharma S, Behera D, Sreenivas V, et al. Prevalence, distribution and functional significance of the -237C to T polymorphism in the IL12Rβ2 promoter in Indian tuberculosis patients. PloS One. 2012;7(4):e34355.
  25. Nolin B. Intensité de pratique d’activité physique: définitions et commentaires. Montréal: Institut national de santé publique du Québec; 2007. 11 p.
  26. Pasquereau A, Andler R, Guignard R, Soullier N, Gautier A, Richard JB, et al. Consommation de tabac parmi les adultes en 2020 : résultats du Baromètre de Santé publique France. Bull Epidemiol Hebd. 2021;(8):132-9.
  27. Institut national de la statistique. | INS [Internet]. 2022 [cité 24 août 2022]. Disponible sur:
  28. Ghannem H, Fredj AH. [Epidemiological transition and cardiovascular risk factors in Tunisia]. Rev Epidemiol Sante Publique. sept 1997;45(4):286-92.
  29. Mazloomzadeh S, Rashidi Khazaghi Z, Mousavinasab N. The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis. Iran J Public Health. avr 2018;47(4):473-80.
  30. Li R, Li W, Lun Z, Zhang H, Sun Z, Kanu JS, et al. Prevalence of metabolic syndrome in Mainland China: a meta-analysis of published studies. BMC Public Health. 1 avr 2016;16:296.
  31. Kelliny C, William J, Riesen W, Paccaud F, Bovet P. Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol. 18 sept 2008;7:27.
  32. Cárdenas Quintana H, Sánchez Abanto J, Roldán Arbieto L, Mendoza Tasayco F. [Prevalence of metabolic syndrome in people 20 years old and more. Peru, 2005]. Rev Esp Salud Publica. avr 2009;83(2):257-65.
  33. Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. août 2009;58(8):1102-8.
  34. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the metabolic syndrome in Latin America and its association with subclinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 26 sept 2009;8:52.
  35. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. juin 2009;32(6):1092-7.
  36. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, ShamahLevy T, Rauda J, Avila-Burgos L, et al. Metabolic syndrome in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex. 2010;52 Suppl 1:S11-18.
  37. Erem C, Hacihasanoglu A, Deger O, Topbaş M, Hosver I, Ersoz HO, et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine. févr 2008;33(1):9-20.
  38. Cao C, Hu H, Zheng X, Zhang X, Wang Y, He Y. Association between central obesity and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching. Sci Rep. 4 août 2022;12:13445.
  39. AlSaraj F, McDermott JH, Cawood T, McAteer S, Ali M, Tormey W, et al. Prevalence of the metabolic syndrome in patients with diabetes mellitus. Ir J Med Sci. sept 2009;178(3):309-13.
  40. Shiferaw WS, Akalu TY, Gedefaw M, Anthony D, Kassie AM, Misganaw Kebede W, et al. Metabolic syndrome among type 2 diabetic patients in Sub-Saharan African countries: A systematic review and meta-analysis. Diabetes Metab Syndr. oct 2020;14(5):1403-11.
  41. Kwasny C, Manuwald U, Kugler J, Rothe U. Systematic Review of the Epidemiology and Natural History of the Metabolic Vascular Syndrome and its Coincidence with Type 2 Diabetes Mellitus and Cardiovascular Diseases in Different European Countries. Horm Metab Res Horm Stoffwechselforschung Horm Metab. mars 2018;50(3):201-8.
  42. Elasmi M, Feki M, Sanhaji H, Jemaa R, Haj Taeib S, Omar S, et al. Prévalence des facteurs de risque cardiovasculaires conventionnels dans la population du Grand Tunis. Rev DÉpidémiologie Santé Publique. 1 avr 2009;57(2):87-92.
  43. De Carvalho Vidigal F, Bressan J, Babio N, Salas-Salvadó J. Prevalence of metabolic syndrome in Brazilian adults: a systematic review. BMC Public Health. 18 déc 2013;13:1198.
  44. Dang AK, Le HT, Nguyen GT, Mamun AA, Do KN, Thi Nguyen LH, et al. Prevalence of metabolic syndrome and its related factors among Vietnamese people: A systematic review and meta-analysis. Diabetes Metab Syndr. avr 2022;16(4):102477.
  45. Bouguerra R, Ben Salem L, Alberti H, Ben Rayana C, El Atti J, Blouza S, et al. Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab. juin 2006;32(3):215-21.
  46. Ben Romdhane H, Haouala H, Belhani A, Drissa H, Kafsi N, Boujnah R, et al. [Epidemiological transition and health impact of cardiovascular disease in Tunisia]. Tunis Med. mai 2005;83 Suppl 5:1-7.
  47. Ghannem H. The challenge of preventing cardiovascular disease in Tunisia. Prev Chronic Dis. janv 2006;3(1):A13.
  48. El Bilbeisi AH, Shab-Bidar S, Jackson D, Djafarian K. The Prevalence of Metabolic Syndrome and Its Related Factors among Adults in Palestine: A Meta-Analysis. Ethiop J Health Sci. janv 2017;27(1):77-84.
  49. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. nov 2005;28(11):2745-9.
  50. Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab Syndr Relat Disord. sept 2008;6(3):177-86.
  51. Fatahi A, Doosti-Irani A, Cheraghi Z. Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis. Int J Prev Med. 2020;11:64.
  52. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 21 janv 2017;17(1):101.
  53. Park YH, Shin JA, Han K, Yim HW, Lee WC, Park YM. Gender difference in the association of metabolic syndrome and its components with age-related cataract: the Korea National Health and Nutrition Examination Survey 2008-2010. PloS One. 2014;9(1):e85068.
  54. Bhupathiraju SN, Stampfer MJ. Menopausal Hormone Therapy and Cardiovascular Disease: Unraveling the Role of Age and Time Since Menopause Onset. Clin Chem. mai 2018;64(5):861-2.
  55. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 24 févr 2003;163(4):427-36.
  56. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol. avr 2004;33(2):328-36.
  57. Kelishadi R, Razaghi EM, Gouya MM, Ardalan G, Gheiratmand R, Delavari A, et al. Association of physical activity and the metabolic syndrome in children and adolescents: CASPIAN Study. Horm Res. 2007;67(1):46-52.
  58. Sobolski J, Kornitzer M, De Backer G, Dramaix M, Abramowicz M, Degre S, et al. Protection against ischemic heart disease in the Belgian Physical Fitness Study: physical fitness rather than physical activity? Am J Epidemiol. avr 1987;125(4):601-10.
  59. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 7 févr 2002;346(6):393-403.
  60. Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 15 mars 2011;57(11):1299-313.
  61. Brien SE, Janssen I, Katzmarzyk PT. Cardiorespiratory fitness and metabolic syndrome: US National Health and Nutrition Examination Survey 1999-2002. Appl Physiol Nutr Metab Physiol Appl Nutr Metab. févr 2007;32(1):143-7.
  62. Zhu S, St-Onge MP, Heshka S, Heymsfield SB. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism. nov 2004;53(11):1503-11.
  63. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 28 août 2007;116(9):1081-93.
  64. Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, et al. Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. oct 2008;93(10):3671-89.
  65. Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Agespecific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 29 août 2007;7:220.
  66. Allard M, Moe G. The Metabolic Syndrome: A Growing Concern [Internet]. 2006 [cité 7 sept 2022]. Disponible sur: https://www.cardiologyrounds. ca/_files/ugd/b076e2_e1b67628af81460e898303b00b99b8ff.pdf.
E-mail :
Password :
Remember Me Forgot password? Sign UP
Keywords most used
Tunisia treatment diagnosis Child surgery prognosis Children Risk factors epidemiology Crohn’s disease prevalence Breast cancer screening obesity Cancer
Sign up to receive our newsletter
E-mail :
Stay in Touch
Join Us! !